Tezcan Gecgil

Tezcan Gecgil

Expertise: ETFs, Options Trading, Technical and Fundamental Analysis

Education: PhD (Business Studies), MSc (Investment Banking & Trading), MBA

Awards & Accomplishments: Completed all 3 levels of the Chartered Market Technician (CMT) qualification

About Tezcan
Tezcan Gecgil, PhD, began contributing to InvestorPlace in 2018. She has worked in investment management in the U.S. and U.K., including a Greenwich, Connecticut-based hedge fund as well as the American Stock Exchange, CFA Institute, and Bloomberg. She has also taught at various U.S. and U.K. universities.

She holds Ph.D. (Business Studies) as well as MSc (Investment Banking & Trading) and MBA degrees from leading U.S. and U.K. universities and has also completed all three levels of the Chartered Market Technician (CMT) examination.

Her passion is for options trading based on technical analysis of fundamentally strong companies. She especially enjoys setting up weekly covered calls for income generation. Publicly, she has also contributed to investing.com and the U.K. website of The Motley Fool. She is also part of the investment management writing team at Copylab.

When not navigating the markets, Tezcan delves into the mysteries of history and explores new destinations.

Recent Articles

Virgin Galactic: SPCE Stock May Take Off to Reach $30

As Test-flight preparations get underway, SPCE stock could be a long-term buy

8 Travel Stocks Celebrating The Positive Vaccine News

A coronavirus vaccine will possibly clear the path for improved earnings for these travel stocks that have suffered in 2020.

7 Of The Best Long-Term Tech Stocks To Buy As Sector Looks Ready to Charge

These seven long-term stocks are likely to bring stable returns to any tech portfolio.

7 Stocks to Sell for December

As we reach the end of 2020, let's take a look at seven stocks to sell whose share prices have had impressive up moves in recent weeks.

Why the Pain In Hexo Shares Is Likely to Continue

Given the company's poor balance sheet, Hexo stock is not likely to create shareholder value in the coming weeks.